Devices and methods for modulation of bone erosion
Devices and methods for stimulation of the vagus nerve to modulate (e.g., reduce, suppress, etc.) bone erosion. Methods and apparatus for modulating bone erosion may modulate levels of Receptor Activator for Nuclear Factor κ B Ligand (RANKL), and/or to modulate (increase, enhance, etc.) osteoprotegerin (OPG) and/or OPG/RANKL ratio. Devices may include electrical stimulation devices that may be implanted, and may be activated to apply current for a proscribed duration, followed by a period without stimulation.
1. A method of treating a metastatic cancer or preventing a cancer from metastasizing, the method comprising applying electrical stimulation to the vagus nerve using a nerve stimulation device to reduce RANKL level within a patient having a metastatic cancer or at risk for developing a metastatic cancer from cancerous or precancerous cells or tissue.
2. The method of claim 1 , wherein the step of applying electrical stimulation to the vagus nerve comprises repeatedly applying electrical stimulation of between about 0.1 and about 10 mA to the patient's vagus nerve for less than about 2 minutes, followed by an off-time of between about 12 and about 48 hours.
3. The method of claim 1 , wherein the metastic cancer is breast cancer, prostate cancer, myelomas, or bone cancers.
4. The method of claim 1 , further comprising placing a nerve cuff around a portion of the subject's vagus nerve.
5. The method of claim 1 , further comprising monitoring the patient's RANKL level.
6. The method of claim 1 , further comprising monitoring a marker related to osteoclast number, activity or number and activity.
7. The method of claim 1 , wherein applying stimulation to the vagus nerve to reduce RANKL level within a patent at risk for metastatic cancer comprises:
stimulating the vagus nerve once a day; and reducing RANKL to between about 80-90%.
8. A method of treating a metastatic cancer or preventing a cancer from metastasizing, the method comprising:
repeatedly applying electrical stimulation of between about 0.1 and about 10 mA to the patient's vagus nerve for less than about 2 minutes, followed by an off-time of between about 12 and about 48 hours, to reduce RANKL; and
monitoring a marker related to RANKL, OPG or RANKL and OPG.
9. The method of claim 8 , further comprising placing a nerve cuff around a portion of the subject's vagus nerve.
10. The method of claim 8 , further comprising monitoring a marker related to the metastatic cancer.
11. The method of claim 8 , further comprising monitoring a marker related to osteoclast number, activity or number and activity.
12. The method of claim 8 , wherein repeatedly applying stimulation to the vagus nerve comprises: stimulating the vagus nerve once a day; and reducing RANKL to between about 80-90%.